GT BIOPHARMA, INC. (GTBP) Deferred Tax Assets, Operating Loss Carryforwards, Domestic

GT BIOPHARMA, INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic

GT BIOPHARMA, INC. (GTBP) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $73.33 million as of 2025-12-31, per its 10-K filed 2026-03-02.

Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-03-02

• 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $73.33M.
• 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $73.40M.
• 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $66.68M.
• 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $66.74M.